QQQ   270.19 (+0.30%)
AAPL   438.96 (+0.74%)
MSFT   213.30 (-1.50%)
FB   251.04 (-0.37%)
GOOGL   1,483.22 (+0.03%)
AMZN   3,150.50 (+1.24%)
NVDA   442.75 (+0.53%)
CGC   19.05 (-0.05%)
BABA   259.57 (+0.63%)
TSLA   1,518.00 (+2.22%)
MU   51.19 (+1.59%)
GE   6.15 (+0.65%)
AMD   81.94 (+5.50%)
F   6.88 (+2.84%)
ACB   10.41 (-0.10%)
GILD   71.32 (-0.57%)
NFLX   506.55 (+1.59%)
DIS   116.29 (-0.05%)
BAC   24.96 (-0.12%)
BA   165.54 (+2.02%)
QQQ   270.19 (+0.30%)
AAPL   438.96 (+0.74%)
MSFT   213.30 (-1.50%)
FB   251.04 (-0.37%)
GOOGL   1,483.22 (+0.03%)
AMZN   3,150.50 (+1.24%)
NVDA   442.75 (+0.53%)
CGC   19.05 (-0.05%)
BABA   259.57 (+0.63%)
TSLA   1,518.00 (+2.22%)
MU   51.19 (+1.59%)
GE   6.15 (+0.65%)
AMD   81.94 (+5.50%)
F   6.88 (+2.84%)
ACB   10.41 (-0.10%)
GILD   71.32 (-0.57%)
NFLX   506.55 (+1.59%)
DIS   116.29 (-0.05%)
BAC   24.96 (-0.12%)
BA   165.54 (+2.02%)
QQQ   270.19 (+0.30%)
AAPL   438.96 (+0.74%)
MSFT   213.30 (-1.50%)
FB   251.04 (-0.37%)
GOOGL   1,483.22 (+0.03%)
AMZN   3,150.50 (+1.24%)
NVDA   442.75 (+0.53%)
CGC   19.05 (-0.05%)
BABA   259.57 (+0.63%)
TSLA   1,518.00 (+2.22%)
MU   51.19 (+1.59%)
GE   6.15 (+0.65%)
AMD   81.94 (+5.50%)
F   6.88 (+2.84%)
ACB   10.41 (-0.10%)
GILD   71.32 (-0.57%)
NFLX   506.55 (+1.59%)
DIS   116.29 (-0.05%)
BAC   24.96 (-0.12%)
BA   165.54 (+2.02%)
QQQ   270.19 (+0.30%)
AAPL   438.96 (+0.74%)
MSFT   213.30 (-1.50%)
FB   251.04 (-0.37%)
GOOGL   1,483.22 (+0.03%)
AMZN   3,150.50 (+1.24%)
NVDA   442.75 (+0.53%)
CGC   19.05 (-0.05%)
BABA   259.57 (+0.63%)
TSLA   1,518.00 (+2.22%)
MU   51.19 (+1.59%)
GE   6.15 (+0.65%)
AMD   81.94 (+5.50%)
F   6.88 (+2.84%)
ACB   10.41 (-0.10%)
GILD   71.32 (-0.57%)
NFLX   506.55 (+1.59%)
DIS   116.29 (-0.05%)
BAC   24.96 (-0.12%)
BA   165.54 (+2.02%)
Log in

OTCMKTS:PCSAProcessa Pharmaceuticals Stock Price, Forecast & News

$8.50
0.00 (0.00 %)
(As of 07/22/2020)
Add
Compare
Today's Range
$8.50
Now: $8.50
$8.50
50-Day Range
$6.00
MA: $7.78
$9.00
52-Week Range
$6.00
Now: $8.50
$21.00
VolumeN/A
Average Volume343 shs
Market Capitalization$46.92 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.62
Processa Pharmaceuticals, Inc., a pharmaceutical company, engages in the clinical development of drug products for the unmet medical needs. Its lead product candidate is PCS-499, an oral tablet for the treatment of necrobiosis lipoidica and radiation-induced fibrosis in head and neck cancer patients. The company is based in Hanover, Maryland.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PCSA
Previous SymbolOTCMKTS:HUWX
CUSIPN/A
CIKN/A
Phone443-776-3133

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$1.46 per share

Profitability

Net Income$-3,360,000.00

Miscellaneous

Employees15
Market Cap$46.92 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable
$8.50
0.00 (0.00 %)
(As of 07/22/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive PCSA News and Ratings via Email

Sign-up to receive the latest news and ratings for PCSA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Processa Pharmaceuticals (OTCMKTS:PCSA) Frequently Asked Questions

How has Processa Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

Processa Pharmaceuticals' stock was trading at $9.75 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PCSA shares have decreased by 12.8% and is now trading at $8.50.
View which stocks have been most impacted by Coronavirus
.

When is Processa Pharmaceuticals' next earnings date?

Processa Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020.
View our earnings forecast for Processa Pharmaceuticals
.

How were Processa Pharmaceuticals' earnings last quarter?

Processa Pharmaceuticals Inc (OTCMKTS:PCSA) posted its quarterly earnings results on Friday, May, 15th. The company reported ($0.16) EPS for the quarter.
View Processa Pharmaceuticals' earnings history
.

Has Processa Pharmaceuticals been receiving favorable news coverage?

Media stories about PCSA stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Processa Pharmaceuticals earned a coverage optimism score of -1.7 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days.
View the latest news about Processa Pharmaceuticals
.

Who are some of Processa Pharmaceuticals' key competitors?

Who are Processa Pharmaceuticals' key executives?

Processa Pharmaceuticals' management team includes the following people:
  • Dr. David Young, Co- Founder, Chairman & CEO (Age 66)
  • Mr. Patrick Lin, Co-Founder, Chief Bus. & Strategy Officer and Director (Age 54)
  • Dr. Sian E. Bigora, Co-Founder & Chief Devel. Officer (Age 59)
  • Ms. Wendy Guy, Co-Founder & Chief Admin. Officer (Age 55)
  • Mr. James H. Stanker, Chief Financial Officer (Age 61)

What is Processa Pharmaceuticals' stock symbol?

Processa Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PCSA."

How do I buy shares of Processa Pharmaceuticals?

Shares of PCSA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Processa Pharmaceuticals' stock price today?

One share of PCSA stock can currently be purchased for approximately $8.50.

How big of a company is Processa Pharmaceuticals?

Processa Pharmaceuticals has a market capitalization of $46.92 million. Processa Pharmaceuticals employs 15 workers across the globe.

What is Processa Pharmaceuticals' official website?

The official website for Processa Pharmaceuticals is www.processapharmaceuticals.com.

How can I contact Processa Pharmaceuticals?

Processa Pharmaceuticals' mailing address is 7380 COCA COLA DRIVE SUITE 106, HANOVER MD, 21076. The company can be reached via phone at 443-776-3133 or via email at [email protected]

This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.